Scientific Advisory Board

The Scientific Advisory Board guides RockStep’s market position and scientific direction.

Ray Pawlicki (Board of Directors)

Ray Pawlicki (Also RockStep Solutions’ Board of Directors).

Current: Board Director, Harvard Pilgrim, UMass Memorial, Healthcare IT

Previous: CIO Biogen, Novarits, Cytec.

Board Member: With his extensive experience in the biopharmaceutical industry, Ray provides RockStep with product positioning, business guidance, and IT strategy.


Amy Salem, Ph.D.

Current: Associate Director -AW Operations at Merck

Previous: Associate Director Regulatory Affairs, University of Pennsylvania.

Board Member: Amy has deep experience in research animal welfare. Amy brings RockStep industry contacts and experience with lab software systems, animal care workflows, and regulatory compliance.



Rainer Fuchs, Ph.D.

Retired:  Chief Information Officer, Harvard Medical School

Previous: President, Provasculon.

Board Member: Rainer is a visionary and often invited keynote speaker industry conferences. Rainer’s experience in biopharma and academia brings a unique perspective to RockStep’s strategic planning sessions.



Jeff  Warhaft

Current: Head of IT at Boston Biomedical

Previous: Director of IT, Biogen.

Board Member: Jeff has deep knowledge of how IT systems and business value intersect to transform research. Jeff brings the perspective how software systems, like Climb, fit into the informatics ecosystems of high throughput drug discovery workflows.



Arthur Hubbs

Retired: Corporate Sr. VP, IT and CIO of Charles River Laboratories

Previous: VP R&D Informatics, Pfizer.

Board Member: Arthurs extensive background in biopharmaceutical companies and CROs provides a unique understanding how both sides of the CRO/customer relationship work. As an IT visionary, Arthur helps guide RockStep’s product direction and